Rolf Angerbauer
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Organic Chemistry top 10%
- Carbohydrate Chemistry and Synthesis
- Synthetic Organic Chemistry Methods
Papers in
-
- Carbohydrate Chemistry and Synthesis 5
- Chemical Synthesis and Reactions 2
-
- Glycosylation and Glycoproteins Research 4
- Plant biochemistry and biosynthesis 2
- Co-authors
- Richard R. Schmidt (7 shared papers)Hilmar Bischoff (4 shared papers)Martin Radtke (3 shared papers)Wolfgang Karl (2 shared papers)Wolfram Steinke (3 shared papers)Armin Kern (2 shared papers)D. Petzinna (2 shared papers)Delf Schmidt (2 shared papers)
- Journals
- Carbohydrate Research (3 papers)Atherosclerosis (3 papers)Drugs of the Future (1 paper)Journal of Labelled Compounds and Radiopharmaceuticals (1 paper)PubMed (2 papers)
- Partner nations
- GermanyUnited States
In The Last Decade
Rolf Angerbauer
14 papers receiving 421 citations
Peers
Comparison fields: 5 of 56
- Pharmacology 67
- Organic Chemistry 201
- Pharmaceutical Science 21
- Biotechnology 29
- Surgery 131
Countries citing papers authored by Rolf Angerbauer
This map shows the geographic impact of Rolf Angerbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Angerbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Angerbauer more than expected).
Fields of papers citing papers by Rolf Angerbauer
This network shows the impact of papers produced by Rolf Angerbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Angerbauer. The network helps show where Rolf Angerbauer may publish in the future.
Co-authors
The 14 scholars most cited alongside Rolf Angerbauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 98 | |
| 2 | Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved. | 1997 | 71 |
| 3 | 1979 | 48 | |
| 4 | 1977 | 48 | |
| 5 | Biotransformation of cerivastatin in mice, rats, and dogs in vivo. | 1998 | 44 |
| 6 | 1981 | 33 | |
| 7 | 1994 | 27 | |
| 8 | 1981 | 26 | |
| 9 | 1977 | 21 | |
| 10 | 1998 | 17 | |
| 11 | 1997 | 13 | |
| 12 | 1979 | 6 | |
| 13 | 1979 | 3 | |
| 14 | 1999 | 2 |
About Rolf Angerbauer
Rolf Angerbauer is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Biotechnology and Surgery, having authored 14 papers that have together received 457 indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (5 papers), Glycosylation and Glycoproteins Research (4 papers), Plant biochemistry and biosynthesis (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Chemical Synthesis and Reactions (2 papers), Microbial Metabolism and Applications (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Pharmacology (67 citations), Organic Chemistry (201 citations), Pharmaceutical Science (21 citations), Biotechnology (29 citations) and Surgery (131 citations). Rolf Angerbauer has collaborated with scholars based in Germany and United States. Frequent co-authors include Richard R. Schmidt, Hilmar Bischoff, Martin Radtke, Wolfgang Karl, Wolfram Steinke, Armin Kern, D. Petzinna, Delf Schmidt, Günter Thomas and Erwin Bischoff. Their work appears in journals such as Carbohydrate Research, Atherosclerosis, Drugs of the Future, Journal of Labelled Compounds and Radiopharmaceuticals and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.